Ferring Sustainability Profile
Ferring Pharmaceuticals, a global biopharmaceutical company headquartered in India, has established itself as a leader in reproductive health, urology, and gastroenterology since its founding in 1950. With a strong presence in Europe, North America, and Asia, Ferring is dedicated to developing innovative therapies that address unmet medical needs. The company is renowned for its core products, including hormone therapies and treatments for various gastrointestinal disorders, which are distinguished by their patient-centric approach and commitment to research and development. Ferring's notable achievements include pioneering advancements in assisted reproductive technology, solidifying its market position as a trusted provider of specialised healthcare solutions. Through its dedication to science and patient care, Ferring continues to make significant contributions to the biopharmaceutical industry.
DitchCarbon Score
How does Ferring's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ferring's score of 21 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ferring's reported carbon emissions
Ferring Group, headquartered in India, has made significant commitments towards reducing its carbon emissions, although specific emissions data for the most recent year is not available. The company has committed to achieving net-zero emissions across all scopes by 2050, with the commitment initiated in 2023. This long-term target aligns with the Science Based Targets initiative (SBTi) framework, which underscores Ferring's dedication to climate action within the pharmaceuticals, biotechnology, and life sciences sector. Ferring's net-zero commitment reflects a proactive approach to sustainability, aiming to mitigate its environmental impact in line with global climate goals. The company is currently in the process of developing specific reduction targets, which will further detail its strategy for achieving these ambitious climate objectives. As of now, Ferring's climate initiatives are not cascaded from a parent organization, indicating a direct commitment from Ferring Holding SA. Overall, Ferring Group's climate commitments demonstrate a strong alignment with industry standards and a clear pathway towards a sustainable future.
How Carbon Intensive is Ferring's Industry?
How Carbon Intensive is Ferring's Location?
Ferring's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ferring has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
